Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project-Reference-Cited by-同舟云学术

Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project

Published:2014-09-22 Issue:9 Volume:9 Page:e107294
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vishram Julie K. K.,Borglykke Anders,Andreasen Anne H.,Jeppesen Jørgen,Ibsen Hans,Jørgensen Torben,Palmieri Luigi,Giampaoli Simona,Donfrancesco Chiara,Kee Frank,Mancia Giuseppe,Cesana Giancarlo,Kuulasmaa Kari,Salomaa Veikko,Sans Susana,Ferrieres Jean,Dallongeville Jean,Söderberg Stefan,Arveiler Dominique,Wagner Aline,Tunstall-Pedoe Hugh,Drygas Wojciech,Olsen Michael H.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Role of insulin resistance in human disease;GM Reaven;Diabetes,1988

2. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women;Q Qiao;Diabetologia,2006

3. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population;JF Ascaso;Eur J Intern Med,2011

4. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome;A Benetos;Am J Cardiol,2008

5. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States of American and European populations;G Assmann;Am J Cardiol,2007

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of metabolic syndrome with telomere length as a marker of cellular aging: a systematic review and meta-analysis;Frontiers in Genetics;2024-07-09

2. Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia;Bulletin of Reproductive Health;2024-06-18

3. High persistence and low treatment rates of metabolic syndrome in patients with mood and anxiety disorders: A naturalistic follow-up study;Journal of Affective Disorders;2024-06

4. The Lipid Accumulation Product Index (LAP) and the Cardiometabolic Index (CMI) Are Useful for Predicting the Presence and Severity of Metabolic Syndrome in Adult Patients with Obesity;Journal of Clinical Medicine;2024-05-11

5. The impact of lifestyle, measured with the HLPCQ questionnaire on the prevalence of metabolic syndrome in Poland: a multicenter study;Scientific Reports;2024-05-02